Breastfeeding Support Strategy for Patients With Gestational Diabetes
Develops breastfeeding support to help prevent type 2 diabetes after gestational diabetes.
Key facts
- Who runs it
- University of California, Davis
- Where
- Sacramento, United StatesSee the site
- Trial code
- Registry title
- Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 23 Mar 2026
- Expected to end
- 30 Dec 2026
- Type of study
- Observational
- Treatments tested
- Implementation mapping to develop a multilevel health system strategy for prevention of type 2 diabetes through targeted breastfeeding support for patients with gestational diabetes
- Record updated
- 14 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had gestational diabetes and are recently pregnant or after giving birth. It also includes health care providers and leaders who would put the breastfeeding support plan into practice.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Gestational diabetes, during pregnancy or after the birth (patients). Health care providers and executive leadership can also join.
Main reasons for not taking part
- People who do not fit one of the three groups: patients with gestational diabetes, health care providers, or executive leadership
- People who cannot communicate in English
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- ≥18 years old and able to communicate in English
- Fits into one of the following:; patients with GDM who are recently pregnant and/or postpartum; health care providers (nurses, physicians, lactation consultants, etc.) who would implement the strategy; executive leadership
Who cannot take part
- Subjects not meeting the inclusion criteria will be considered ineligible for participation
Where in United States
- UC Davis Medical CenterSacramento, United StatesContact: Elva Horath, MDTaking people
About the trial
What the trial wants to find out
The investigators will use implementation methods to develop better breastfeeding support for patients with gestational diabetes as a way to prevent type 2 diabetes.
The group in the trial
- Panel of key informants
The informant panel will include pregnant or postpartum individuals with a diagnosis of GDM. Staff at the UC Davis Health Campus including health care providers and staff who would be involved in implementing the breastfeeding support strategy and department leadership. All participants will be ≥18 years old and able to communicate in English
Treatment: Implementation mapping to develop a multilevel health system strategy for prevention of type 2 diabetes through targeted breastfeeding support for patients with gestational diabetes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Preventing Type 2 Diabetes Following Gestational Diabetes: Implementation Mapping for a Multilevel Breastfeeding Support Strategy
- Plain-language title
- Breastfeeding Support Strategy for Patients With Gestational DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 September 2026